WO2025195443 - MULTI-SPECIFIC ANTIBODY THAT SPECIFICALLY BINDS TO LIGHT AND C5A, AND COMPOSITION AND USE THEREOF
National phase entry is expected:
Publication Number
WO/2025/195443
Publication Date
25.09.2025
International Application No.
PCT/CN2025/083664
International Filing Date
20.03.2025
Title **
[English]
MULTI-SPECIFIC ANTIBODY THAT SPECIFICALLY BINDS TO LIGHT AND C5A, AND COMPOSITION AND USE THEREOF
[French]
ANTICORPS MULTI-SPÉCIFIQUE SE LIANT DE MANIÈRE SPÉCIFIQUE À LIGHT ET À C5A, COMPOSITION ET UTILISATION ASSOCIÉES
[Chinese]
特异性结合LIGHT和C5a的多特异性抗体以及组合物及其应用
Applicants **
BEIJING SOLOBIO GENETECHNOLOGY CO., LTD.
Inventors
WANG, Guangfei
LI, Zhong
FAN, Jundie
ZHANG, Si
HAN, Wuyang
ZHANG, Miaomin
WANG, Guowu
YU, Debin
CUI, Jinglan
Priority Data
PCT/CN2024/082935
21.03.2024
CN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
CNIPA
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2349 | |
| EPO | Filing, Examination, Granting | 17260 | |
| Japan | Filing, Examination, Granting | 2424 | |
| South Korea | Filing, Examination, Granting | 2550 | |
| USA | Filing, Examination, Granting | 5140 |
Total:
29,723
Contact Us
Abstract[English]
Provided are a multi-specific antibody or antigen-binding fragment that specifically binds to LIGHT and C5a, a composition containing an antibody or antigen-binding fragment that specifically binds to LIGHT and an antibody or antigen-binding fragment that specifically binds to C5a, a pharmaceutical composition containing the multi-specific antibody or the composition, and preparation methods therefor and the uses thereof, including a method for preventing and treating inflammatory, respiratory or autoimmune diseases by using same.[French]
L'invention concerne un anticorps multi-spécifique ou un fragment de liaison à l'antigène qui se lie de manière spécifique à LIGHT et à C5a, une composition contenant un anticorps ou un fragment de liaison à l'antigène qui se lie de manière spécifique à LIGHT et un anticorps ou un fragment de liaison à l'antigène qui se lie de manière spécifique à C5a, une composition pharmaceutique contenant l'anticorps multi-spécifique ou la composition, et leurs procédés de préparation et leurs utilisations, comprenant une méthode de prévention et de traitement de maladies inflammatoires, respiratoires ou auto-immunes l'utilisant.[Chinese]
提供了特异性结合LIGHT和C5a的多特异性抗体或抗原结合片段，包含特异性结合LIGHT的抗体或抗原结合片段和特异性结合C5a的抗体或抗原结合片段的组合物，以及包含上述多特异性抗体或组合物的药物组合物、其制备方法和用途，包括用其预防和治疗炎症性、呼吸或自身免疫性疾病的方法。